REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro De Neurociencias Del Caribe Sas (Colombia)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Ambulatory Health Care Services | Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities | Other Residential Care Facilities
Full name: Centro De Neurociencias Del Caribe Sas Profile Updated: January 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Centro De Neurociencias Del Caribe Sas is an enterprise located in Colombia, with the main office in Magangue. It operates in the General Medical and Surgical Hospitals industry. The company was established on October 25, 2021. The company’s latest financial report indicates a net sales revenue increase of 184.3% in 2025. Its’ total assets recorded a growth of 42.61%. The net profit margin of Centro De Neurociencias Del Caribe Sas decreased by 0.9% in 2025.

Headquarters
Cl 14 46 50 Brr Miraflores
Magangue; Bolivar;

Contact Details: Purchase the Centro De Neurociencias Del Caribe Sas report to view the information.

Basic Information
Registered Capital:
Purchase the Centro De Neurociencias Del Caribe Sas report to view the information.
Financial Auditors:
Purchase the Centro De Neurociencias Del Caribe Sas report to view the information.
Incorporation Date:
October 25, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro De Neurociencias Del Caribe Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
184.3%
Total Operating Revenue
184.3%
Operating Profit
150.25%
EBITDA
150.25%
Net Profit/Loss for the Period
81.95%
Total Assets
42.61%
Total Equity
27.08%
Operating Profit Margin
-0.36%
Net Profit Margin
-0.9%
Return on Equity (ROE)
7.57%
Quick Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?